Presidio Medical, Inc.
1 Book found

Presidio Medical, Inc. books

KEY TAKEAWAYS:

  • Novel Ultra Low Frequency (ULF™) neuromodulation inhibits pain signals in pre-clinical animal models, computational models, and in a clinical trial
  • The mechanism of ULF™ neuromodulation is unique, enabling controlled and reversible inhibition of pain neurons through sodium channel inactivation. This mechanism of action is different than existing SCS technologies, which work by activating neurons
  • In a clinical trial, pa

Contact supplier

Drop file here or browse